Jan 15, 2013 by Dan CarrollNorthrop Grumman Awarded $9.2 Million Army ContractContractor has supplied more than 25,000 similar targeting devices to date
Jan 15, 2013 by Dan CarrollNetflix Signs Deal for Warner Brothers, Turner Broadcasting ContentAgreement brings Cartoon Network and TNT's "Dallas" to Netflix
Jan 14, 2013 by Dan CarrollA Rough Road Ahead for Europe in 2013Keep your investments in this troubled region close this year.
Jan 14, 2013 by Dan CarrollTech Blues Weigh on the DowDespite HP's spectacular day, the Dow can't manage a breakout.
Jan 14, 2013 by Dan CarrollWhy You Should Ignore the MAKO Surgical PanicThe sustained sell-off shouldn't shake your long-term conviction in this stock
Jan 14, 2013 by Dan CarrollLevel 3 Communications Inks NATO DealAgreement will task Level 3 affiliate with installing, maintaining IP Virtual Private Network.
Jan 14, 2013 by Dan CarrollWebsense Names New CEOPresident John McCormack takes over as CEO; Gene Hodges signs consulting contract.
Jan 14, 2013 by Dan Carroll"Zero Dark Thirty" Tops Weekend Box OfficeFirst weekend of wide release records $24 million for the CIA thriller
Jan 11, 2013 by Dan CarrollAbbott Begins Clinical Trial of Absorb StentTrial will support potential submission for FDA approval.
Jan 11, 2013 by Dan CarrollAirplane Woes Keep the Dow GroundedBoeing shareholders send the stock down again after the FAA launches a 787 review.
Jan 11, 2013 by Dan CarrollFord to Hire 2,200 Salaried U.S. Workers This YearIn addition to 8,100 hourly and salaried jobs added last year in U.S.
Jan 11, 2013 by Dan CarrollPhase 3 Data Backs Novartis' AfinitorMore support for already-approved drug to treat kidney tumors
Jan 11, 2013 by Dan CarrollBoeing Consolidating Facilities, Cutting Jobs in TexasMove comes in light of U.S. defense budget cuts
Jan 11, 2013 by Dan CarrollCaterpillar Opens 2 New Facilities in ChinaProving grounds and manufacturing plant support emerging-markets operations.
Jan 10, 2013 by Dan CarrollBaxter Announces Successful Phase 3 StudyHemophilia treatment FEIBA NF shows significant reduction in bleeding with prophylaxis treatment
Jan 10, 2013 by Dan CarrollShould You Invest Like Sherlock Holmes?Healthcare investors must weigh focusing too heavily on specific industries versus taking a broad view
Jan 10, 2013 by Dan CarrollThe Dow Gets a Booster Shot From Big PharmaDespite Microsoft's downgrade, the index stays on an upbeat path.
Jan 9, 2013 by Dan CarrollShould Any Big Pharma Buy Bausch & Lomb?Private equity firm Warburg Pincus is asking a lot for the eye-care giant
Jan 9, 2013 by Dan CarrollCell Therapeutics Opens Phase 3 Trial Enrollment for PacritinibStudy to examine company's myelofibrosis drug pacritinib.
Jan 9, 2013 by Dan CarrollThe Dow Beats Back Weekly LossesAfter two days in the red, markets are gaining once again today.
